Moberg Pharma AB (publ)
STO:MOB

Watchlist Manager
Moberg Pharma AB (publ) Logo
Moberg Pharma AB (publ)
STO:MOB
Watchlist
Price: 11.84 SEK -6.55%
Market Cap: 552.8m SEK
Have any thoughts about
Moberg Pharma AB (publ)?
Write Note

Moberg Pharma AB (publ)
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Moberg Pharma AB (publ)
Interest Income Expense Peer Comparison

Comparables:
CALTX
CAMX
S
SECARE
IRLAB A
I
FLERIE

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Moberg Pharma AB (publ)
STO:MOB
Interest Income Expense
kr2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Calliditas Therapeutics AB
STO:CALTX
Interest Income Expense
-kr115.2m
CAGR 3-Years
-23%
CAGR 5-Years
-133%
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Interest Income Expense
kr56m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Interest Income Expense
-kr97.3m
CAGR 3-Years
-177%
CAGR 5-Years
-219%
CAGR 10-Years
N/A
IRLAB Therapeutics AB
STO:IRLAB A
Interest Income Expense
kr2.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Interest Income Expense
kr42.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Moberg Pharma AB (publ)'s Interest Income Expense?
Interest Income Expense
2m SEK

Based on the financial report for Dec 31, 2023, Moberg Pharma AB (publ)'s Interest Income Expense amounts to 2m SEK.

What is Moberg Pharma AB (publ)'s Interest Income Expense growth rate?
Interest Income Expense CAGR 1Y
186%

Over the last year, the Interest Income Expense growth was 186%.

Back to Top